Long COVID with POTS and MCAS, much better on low-dose tirzepatide
- Condition
- Long COVID
- At worst
- Not stated
- Ill before improving or writing
- 4.5 years
- Last post
- Nov 2025
In their words
- Condition: Long COVID
4 years LC/Pots/MCAS, low dose GLP-1 helping SO much
In context ↗ - Now: Much better
All the same my quality of life, cognitive function, energy is 4x what it was pre-GLP-1. ... it’s not a cure and my biggest lingering complaint is my nervous system is still hyper sensitive to stressors
In context ↗ - Began after: COVID
4 years LC/Pots/MCAS
In context ↗
Read from 7 of their posts and comments; links to the 4 this page draws on
Summary
Four and a half years into long COVID with POTS and MCAS, this user had brain fog, exhaustion and new physical anxiety and insomnia, and had tried many off-label drugs. Low-dose compounded tirzepatide cleared the brain fog and eased POTS and MCAS within 48 hours, giving about four times the daily energy. Stress still triggers POTS flares, adrenaline dumps and insomnia, so it is not a cure.
Ask Miruvor AI
What they tried
What they credit
Their words about each treatment
- low dose GLP-1 (trizepatide compound) · Helped a lot
A low dose GLP-1 has been by far the most effective for my LC symptoms of everything. And it was quite immediate.
In context ↗ - LDN · No change
LDN didn’t do much for me, unfortunately
In context ↗ - Guanfacine · Helped
I also previously was taking and continue Guanfacine and Propranolol as well to help with Norepinephrine
In context ↗ - Propranolol · Helped
Propranolol, LDN, Guanfacine, stabilizing mast cells (low dose glp-1 changed my life with this).
In context ↗ - Adderall · Helped
Guanfacine, Propranolol, Adderall are major for me as well.
In context ↗ - Hydroxyzine · Helped
Hydroxyzine for my sleep/anxiety and it does help a lot a lot.
In context ↗ - somatic based therapy · Not said
I still do very somatic based therapy but it can only do so much.
In context ↗
Approaches: GLP-1 drugs · Beta-blockers · Other drugs and medicines · Stimulants
Their path
How ill they were on the ME/CFS severity scale, estimated from what they describe at each point, with time counted from when the illness began. Hover or tap a point. The chart starts 4.2 years after onset: the story doesn’t say how ill they were before that. 1 step says too little to place on the scale and is only in the table. Dates are when they posted. What the levels mean.
Show as a table
| When | What happened | Where they were | After |
|---|---|---|---|
| ~2021 | Long COVID with POTS and MCAS began4 years LC/Pots/MCASIn context ↗ | Not stated | |
| ~2025-07 | Low-dose tirzepatide cleared brain fog and eased POTS and MCAS within 48 hoursWithin 48 hours I was functioning at a level I havent for 4 years.In context ↗ | Mild | Tirzepatide (Mounjaro, Zepbound) |
| 2025-11-25 | Still on low-dose tirzepatide, helping a lot and bouncing back faster from flaresnothing has helped as muchIn context ↗ | Mild | Tirzepatide (Mounjaro, Zepbound) |
Symptoms mentioned
Their words about their symptoms
- Brain fog
Brain fog disappeared
In context ↗ - POTS & dysautonomia
stressors will now send me into POTs flares
In context ↗ - Mast cell (MCAS) & allergies
4 years LC/Pots/MCAS
In context ↗ - Sleep problems
adrenaline dumps, insomnia
In context ↗ - Anxiety & low mood
high physical anxiety
In context ↗ - Anxiety & low mood
I actually never experienced anxiety before LC
In context ↗
Ask Miruvor AI
Similar stories
-
Off work with long COVID brain fog and PEM, now much better with medication
A man who got long COVID in April 2022 had brain fog, PEM, pressure headaches and anxiety, and was at worst off work. Guanfacine, higher-dose Effexor with Buspar, Adderall, low-dose naltrexone and low-dose tirzepatide helped, though the naltrexone boost…
-
80% bedbound with ME/CFS, much better after low-dose tirzepatide
A 44-year-old woman became ill after a viral infection in 2011, worsened to about 80% bedbound by 2019, and clawed back to moderate-severe with a mix of medications. In December 2025 she started low-dose tirzepatide at 0.25 mg weekly, titrating to 1.25 mg…
-
Often housebound with ME/CFS, somewhat better with LDN and cromolyn
Sequoia 90928, a woman, dated her suspected ME/CFS to a likely COVID infection in July 2022 and last worked in March 2023. Through 2023-24 she was often mostly housebound and in bed around 60-70% of the day, sometimes more. No single treatment restored her:…
-
Long COVID brain fog, POTS, insomnia; somewhat better with antihistamines, aggressive rest
She lost smell and taste after COVID in March 2020 and recovered spontaneously about two and a half years later. A second infection in January 2023 brought brain fog, POTS, insomnia and CFS; she stopped working. LDN made her much worse; antihistamines with…